Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-10-25
pubmed:abstractText
We evaluated the cytotoxic effects of combining suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, with taxanes in human gastric cancer cell lines and assessed the pre-treatment difference of gene expression to identify genes that could potentially mediate the cytotoxic response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1432-1335
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1901-13
pubmed:meshHeading
pubmed-meshheading:20217129-Algorithms, pubmed-meshheading:20217129-Animals, pubmed-meshheading:20217129-Antineoplastic Agents, pubmed-meshheading:20217129-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20217129-Cell Line, pubmed-meshheading:20217129-Cell Line, Tumor, pubmed-meshheading:20217129-Cell Proliferation, pubmed-meshheading:20217129-Cell Survival, pubmed-meshheading:20217129-Cluster Analysis, pubmed-meshheading:20217129-Dose-Response Relationship, Drug, pubmed-meshheading:20217129-Drug Synergism, pubmed-meshheading:20217129-Female, pubmed-meshheading:20217129-Gene Expression Profiling, pubmed-meshheading:20217129-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20217129-Humans, pubmed-meshheading:20217129-Hydroxamic Acids, pubmed-meshheading:20217129-Inhibitory Concentration 50, pubmed-meshheading:20217129-Mice, pubmed-meshheading:20217129-Mice, Inbred BALB C, pubmed-meshheading:20217129-Mice, Nude, pubmed-meshheading:20217129-Stomach Neoplasms, pubmed-meshheading:20217129-Taxoids, pubmed-meshheading:20217129-Xenograft Model Antitumor Assays
pubmed:year
2010
pubmed:articleTitle
Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells.
pubmed:affiliation
Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, #134 Shinchon-Dong, Seodaemoon-gu, Seoul 120-752, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't